We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Antibacterial Bandages Designed to Self-Dissolve

By HospiMedica International staff writers
Posted on 28 Jan 2019
A new study describes a biocompatible wound dressing that does not require changing; once the antibiotic is administered, the bandages gradually dissolve on the skin.

Developed at the Russian National University of Science and Technology (MISiS; Moscow, Russia), Masaryk University (Brno, Czech Republic), the Central European Institute of Technology (Brno, Czech Republic), and other institutions, the dressing is based on the antibiotic Gentamicin, immobilized onto plasma coated polycaprolactone (PCL) nanofibers. More...
The Gentamicin loaded nanofibers show a pronounced antibacterial effect that lasts for up to 48 hours, with the bandages gradually dissolving on the skin. A new dressing can then be applied directly on top of the old one.

In an experiment conducted against three strains of Escherichia coli, positive pharmacodynamics were observed, with the strongest effects seen when the Gentamicin was immobilized using ionic bonding (PCL-MA-GMi) and covalent bonding (PCL-MA-GMc). In both cases, the inhibition zone reached 27 mm in diameter, indicating a strong antibacterial effect against all types of E. coli. The researchers are now planning to increase the effectiveness of the material by creating multi-layer dressings that include an antibiotic, heparin, and another layer of antibiotic. The study was published in the September 2018 issue of Science Direct.

“As a basis for our material, we used polycaprolactone nanofibers, which are self-dissolvable. We attached gentamicin, a broad- spectrum antibiotic, to the fibers. Interestingly, the effect has turned out to be prolonged,” said lead author Elizaveta Permyakova, MSc, of the MISiS Inorganic Nanomaterials lab. “We observed a significant decrease in the number of bacteria even 48 hours after the application of the material. Usually surfaces with antibacterial effect work only during the first day, often even the first hours of application.”

Related Links:
Russian National University of Science and Technology
Masaryk University
Central European Institute of Technology


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.